MEDICAL ADVISORY: Recent Pertussis Cases in NiagaraIssued by: Dr. Jessica Jackman, MD MPH FRCPC FACPM DipABLM, Associate Medical Officer of Health Date: August 12, 2024 Niagara Region Public Health and Emergency Services has seen several pertussis cases in recent weeks. While there is no outbreak activity in Niagara Region, given the recent increase in pertussis activity across Ontario, we would like to provide recommended actions for health care providers. This includes recommendations for vaccination, testing and reporting suspect cases to Public Health. About Pertussis - Pertussis is a respiratory infection caused by the bacteria Bordetella pertussis
- The incubation period ranges from six to 20 days
- Pertussis is transmitted through contact with respiratory droplets. Patients are highly communicable during the first two weeks of illness. Communicability gradually decreases and becomes negligible in about three weeks.
- The clinical course of pertussis is divided into three stages:
- Catarrhal stage: characterized by mild upper respiratory tract symptoms, with a mild cough that lasts one to two weeks
- Paroxysmal stage: characterized by repeated and violent coughing (paroxysms), often accompanied by a high-pitched inspiratory whoop and post-tussive vomiting; fever is absent or minimal. This stage lasts one to two months, or longer.
- Convalescent stage: this marks a gradual period of recovery where the cough becomes less paroxysmal and disappears over the course of weeks to months
- Young infants are at highest risk of developing severe complications from pertussis
Actions for Health Care Providers - Please ensure your patients are up-to-date with their routine vaccinations, including pertussis, as per Ontario's routine immunization schedule. This is particularly important as we approach the start of a new school year. Routine immunizations include:
- A series of DTaP-IPV-Hib for infants at two, four, six and 18 months; a booster of Tdap-IPV at four years of age; and an adolescent Tdap booster at 14 – 16 years of age
- A booster dose of Tdap for adults, typically given at 24 – 28 years of age, 10 years from adolescent booster
- One dose of Tdap vaccine should be administered in every pregnancy, ideally between 27 and 32 weeks of gestation. This helps confer protection against pertussis for the infant.
- You may see an increase in the number of calls to your office from
parents/legal guardians seeking vaccinations for their child/children. Please ensure your office has enough vaccine to accommodate this potential increased demand. Use the General Vaccine Order Form for Immunization of School Pupils Act (ISPA) required vaccines.
- Consider pertussis in your differential diagnosis, particularly in patients with coughing spells that end in a high-pitched whoop or vomiting, shortness of breath or exhaustion from coughing, or with a cough lasting two weeks or longer
Pertussis
Testing Infection Prevention and Control - Suspect cases should be placed under droplet precautions, in addition to routine practices. This includes masking of the patient and modifying patient flow to minimize potential exposure to others.
Reporting - All suspect and confirmed cases of pertussis are to be reported to the Medical Officer of Health as per the Health Protection and Promotion Act. To report, please contact the Infectious Disease Program at:
- 905-688-8248 ext. 7330 (8:30 a.m. to 4:30 p.m.)
- Toll free:
1-888-505-6074
- After-hours: 905-984-3690
For More Information
|